Lexaria Bioscience Balance Sheet Health
Financial Health criteria checks 6/6
Lexaria Bioscience has a total shareholder equity of $9.7M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $10.0M and $271.4K respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$8.51m |
| Equity | US$9.75m |
| Total liabilities | US$271.38k |
| Total assets | US$10.02m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: LEXX's short term assets ($9.1M) exceed its short term liabilities ($156.0K).
Long Term Liabilities: LEXX's short term assets ($9.1M) exceed its long term liabilities ($115.3K).
Debt to Equity History and Analysis
Debt Level: LEXX is debt free.
Reducing Debt: LEXX had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: LEXX has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: LEXX has sufficient cash runway for 1.7 years if free cash flow continues to reduce at historical rates of 13.8% each year.